Pharmacological treatment of obstructive sleep apnea with a combination of pseudoephedrine and domperidone.
OBJECTIVE
To determine the effect of the drug combination domperidone and pseudoephedrine on nocturnal oximetry measurements and daytime sleepiness in patients with obstructive sleep apnea.


METHODS
We recruited patients with severe snoring and apneic episodes willing to undergo repeated nocturnal oximetry testing. Following baseline clinical history, Epworth Sleepiness Scale administration, and home overnight nocturnal oximetry, patients were started on weight-adjusted doses of domperidone and pseudoephedrine. Follow-up oximetry studies were performed at the patient's convenience. On the final visit, a repeat clinical history, Epworth score, and oximetry were obtained.


RESULTS
Seventeen of 23 patients noted disappearance of snoring and apneic episodes. Another 2 patients reported improvement in snoring and no apneic episodes. All but one patient had a decrease in Epworth scores (mean decrease 9.4 (95% CI, 6.8-12.1, p < 0.0001). Mean oxygen saturation (2.5; 95% Cl, 0.66-4.41, p = 0.008), percent time with oxygen saturation < 90% (14.8; 95% CI, 24.4 to 5.2, p = 0.003), and the 4% oxygen desaturation index (18.2; 95% CI, 27.3 to 9.1, p < 0.0001) improved significantly. No adverse effects of treatment were noted.


CONCLUSIONS
The combination of domperidone and pseudoephedrine improved self reported snoring and sleepiness, and may have improved apneic episodes and sleep-related nocturnal oxygen desaturation in patients with obstructive sleep apnea provided the proportion of time spent asleep did not diminish. This drug combination warrants further study as a treatment for obstructive sleep apnea.


BACKGROUND
Obstructive sleep apnea; oximetry; sleepiness; domperidone; pseudoephedrine; pharmacotherapy; desaturation; treatment


BACKGROUND
Larrain A; Kapur VK; Gooley TA; Pope CE. Pharmacological treatment of obstructive sleep apnea with a combination of pseudoephedrine and domperidone.
Larrain
Augusto
A
Clinica Servet, Santiago, Chile.
Kapur
Vishesh K
VK
Gooley
Ted A
TA
Pope
Charles E
CE
D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004294:Domperidone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010092:Oximetry / Q000379:methods; D010100:Oxygen / Q000378:metabolism; D054199:Pseudoephedrine / Q000627:therapeutic use*; D020181:Sleep Apnea, Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D000932:Antiemetics; D001993:Bronchodilator Agents; D004294:Domperidone; D054199:Pseudoephedrine; D010100:Oxygen
Chest. 1993 Jan;103(1):30-6
8417909
Am J Respir Crit Care Med. 2001 Jan;163(1):19-25
11208620
Laryngoscope. 2001 Dec;111(12):2144-6
11802013
Eur Respir J. 1999 Feb;13(2):418-23
10065691
Sleep Med Rev. 2008 Feb;12(1):33-47
18201662
Respir Physiol. 1986 Aug;65(2):169-80
3764121
Curr Opin Pulm Med. 2001 Nov;7(6):372-80
11706311
Br J Clin Pharmacol. 2007 Nov;64(5):591-602
17578485
Respir Physiol. 1989 Jun;76(3):327-36
2749032
J Clin Sleep Med. 2006 Jan 15;2(1):21-5
17557432
Ann Pharmacother. 1999 Apr;33(4):429-40
10332535
Am J Respir Crit Care Med. 2006 Jan 1;173(1):7-15
16284108
Otolaryngol Head Neck Surg. 2008 Aug;139(2):286-90
18656731
N Engl J Med. 2000 May 11;342(19):1378-84
10805822
Sleep. 2006 Aug;29(8):1036-44
16944672
Chest. 2009 Jan;135(1):86-93
18689584